Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03954574 · ClinicalTrials.gov registry record

Pulmonary Hemodynamics During Exercise - Research Network

A clinical trial of Pulmonary Circulation Diseases, sponsored by Medical University of Graz.

Recruiting
Registry status
1,500
Enrollment target
20
Study locations

NCT03954574: Recruiting study of Pulmonary Circulation Diseases, sponsored by Medical University of Graz.

NCT03954574 is a study of Pulmonary Circulation Diseases that is actively recruiting participants, run by Medical University of Graz. The registered enrollment target is 1,500 participants. The trial reports 20 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03954574, a study of Pulmonary Circulation Diseases, is actively recruiting participants, sponsored by Medical University of Graz.

RECRUITING
Registry status
1,500 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this Clinical Research Collaboration is to investigate the prognostic implications of pulmonary hemodynamics during exercise based on a large scale multi-centre approach by using retrospective and prospective analysis of hemodynamic data.

Primary Outcome

The investigators aim to assess the prognostic relevance of pulmonary hemodynamics during exercise as assessed by right heart catheterization by using a multi-centre approach and to identify independent predictors of adverse events. Separate data sets will be analysed for the retrospective and prospective Evaluation.

Interventions

  • DIAGNOSTIC_TEST assessment of pulmonary hemodynamics during exercise by right heart catheterization

Study Locations (20)

Other

  • Royal Prince Alfred Hospital, Respiratory Medicine - Camperdown
  • Medical University of Graz - Graz
  • Free University of Brussels, Faculty of Medicine, Physiology - Brussels
  • University of São Paulo Medical School - São Paulo
  • Department of Cardiology, Aarhus University Hospital, Denmark - Aarhus
  • Université de Lorraine - Nancy
  • Centre Chirurgical Marie Lannelongue, Thoracic and Vascular Surgery - Paris
  • Centre de Référence de l'Hypertension Pulmonaire, Université ParisSud - Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris - Paris
  • Sorbonne Universités, Neurophysiologie respiratoire expérimentale et clinique - Paris
  • University of Cologne, Klinik III fuer Innere Medizin - Cologne
  • Justus-Liebig-University Giessen, Department of Internal Medicine - Giessen
  • University of Greifswald - Greifswald

Massachusetts

  • Massachusetts General Hospital, Cardiology Division and Pulmonary Unit - Boston
  • Harvard Medical School, Brigham and Women's Hospital - Boston

Minnesota

  • University of Minnesota Medical School, Division of Cardiology, Department of Medicine, Lillehei Heart Institute Minneapolis, Minnesota, USA - Minneapolis
  • Mayo Clinic, Division of Cardiovascular Diseases, Department of Medicine - Rochester

Arizona

  • University of Arizona, Banner University Medical Center - Phoenix

California

  • University of California, Los Angeles, Lung & Heart-Lung Transplant and Pulmonary Hypertension Programs, David Geffen School of Medicine - Los Angeles

Maryland

  • Johns Hopkins Hospital, Advanced HF, MCS, Transplant Cardiology, Baltimore, Maryland, USA - Baltimore

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2018-12-01
Est. Completion 2029-12-31
Medical University of Graz

1 total trials

What NCT03954574 shows while recruiting

NCT03954574 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Pulmonary Circulation Diseases appearing as the primary indexed condition, and to 1 intervention - of which assessment of pulmonary hemodynamics during exercise by right heart catheterization is the first listed.

NCT03954574 names 20 study sites across 7 states, led by Other, Massachusetts, Minnesota.

Frequently Asked Questions

What is clinical trial NCT03954574 about?

NCT03954574 is a clinical study titled "Pulmonary Hemodynamics During Exercise - Research Network". The purpose of this Clinical Research Collaboration is to investigate the prognostic implications of pulmonary hemodynamics during exercise based on a large scale multi-centre approach by using retrospective and prospective analysis of hemodynamic data.

What is the current status of trial NCT03954574?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2018-12-01. Estimated completion is 2029-12-31.

What conditions does trial NCT03954574 study?

This clinical trial studies the following conditions: Pulmonary Circulation Diseases.

What interventions are being tested in trial NCT03954574?

The interventions under investigation include: assessment of pulmonary hemodynamics during exercise by right heart catheterization (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03954574?

This trial is sponsored by Medical University of Graz, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03954574 being conducted?

This trial has 20 study locations across Arizona, California, Maryland, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03954574, the US trial registry maintained by the National Library of Medicine. NCT03954574 (large enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.